Currently, the share price for Mankind Pharma Ltd. is delayed. Login to view live prices.
Mankind Pharma Ltd.
₹2,557.50
NSE
-- ( -- %) 1D
- Prev. Close2,557.50
- Upper Circuit3,069.00
- Lower Circuit2,046.00
Analyst Sentiment For Mankind Pharma Ltd.
As recommended by 17 analysts
Returns
Mankind Pharma Ltd.'s Info & Management
Founded in 1991, Mankind Pharma Limited is a leading pharmaceutical company. The company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, and several consumer healthcare products. The company is based in New Delhi, India.
Business Segment
Its business operations include:
- Key Therapeutic Segments: covers anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynaecology, and pain/analgesics, urology, ophthalmology among others
- Brand Portfolio: includes Nurokind, Telmikind, Manforce, Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt-M, and others
Geographical Presence
It operates within and outside India.
- Executive Director,Whole Time Director,Chief Executive OfficerSHEETAL ARORA
- Director(Technology.)Mr. Chanakya Juneja
- Company Secretary,Compliance OfficerHitesh Kumar Jain
- President(Strategy)Mr. Prakash Agarwal
- Chief Risk Officer,Vice President(EHS)Mr. Suresh Raju Penmetsa
- Chief Marketing OfficerDr. Sanjay Koul
FAQs on Mankind Pharma Ltd.
What is the share price of Mankind Pharma Ltd.?
Mankind Pharma Ltd. share price is ₹2,562.10 as of April 28, 2025, 01:43 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Mankind Pharma Ltd.?
The 52-week high and low of Mankind Pharma Ltd. is ₹3,050.10 and ₹1,910.00 respectively as of April 28, 2025, 01:43 PM.
52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PB ratio of Mankind Pharma Ltd.?
The trailing twelve month (TTM) PB ratio of Mankind Pharma Ltd. is 10.94 as of April 28, 2025. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Mankind Pharma Ltd.?
The Upper Circuit of Mankind Pharma Ltd. is ₹3,069.
The Lower Circuit of Mankind Pharma Ltd. is ₹2,046.
What is the ROE of Mankind Pharma Ltd.?
Mankind Pharma Ltd. reported an ROE of 22.77% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Mankind Pharma Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Mankind Pharma Ltd., Promoter held 72.7%, the FII held 12.9%, DII held 11.5% and the public held 2.9% of the total shares.
How to buy Mankind Pharma Ltd. Share?
You can easily buy shares of Mankind Pharma Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
What is the fair value of Mankind Pharma Ltd.?
The fair value of Mankind Pharma Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer